The Europe market for cardiac assist devices is estimated at $396.6 Million in 2016 and is poised to reach $602.4 Million by 2021, growing at a CAGR of 8.72%.
Diseases of the heart and circulatory system (cardiovascular disease or CVD) are the main cause of death in Europe: accounting for over 4 million deaths each year. Nearly half (47%) of all deaths are from CVD (52% of deaths in women and 42% of deaths in men).
The main forms of CVD are coronary heart disease (CHD) and stroke
To meet the increasing demand for cardiac therapies in the European countries, the Cardiac Assist Devices (CAD) are used in patients suffering from End-Stage Congestive Heart Failure, where the chances of survival through medications alone is minimal. These devices are used as a Bridge-To-Transplantation (BTT), Bridge-To-Recovery (BTR) or Destination Therapy (DT), depending on the requirement of the patient and the severity of the disease.
Get a comprehensive overview of the Europe cardiac assist devices Market: www.marketdataforecast.com/market-…evices-market-30/
Existence of alternative treatment like pacemaker, heart transplantation and. and the associated compatibility issues with the device implantation, such as respiratory failure, development of blood clots and device failure restrain the market growth.
Adding to these, surgical impediments such as kidney failure, bleeding, Infection and occurrence of stroke are also acting as a barrier in the adoption of such devices.
The Europe cardiac assist devices market is segmented on the basis of type into Ventricular Assist Devices (VAD), Intra-Aortic Balloon Pumps (IABP) & Total Artificial Heart (TAH). Further the Ventricular Assist Devices is divided into Right Ventricular Assist Device (RVAD), Left Ventricular Assist Device (LVAD), Bi-Ventricular Assist Device (Bi-VAD) & External Ventricular Assist Devices.
Get accurate market forecast and analysis on the Europe cardiac assist devices Market Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-…30/request-sample
In addition, On the basis of geography, the European market is analysed under various regions namely, Spain, Germany, UK, France, Italy. The Europe region accounts to about 16% of the Global cardiac assist devices market.
Thoratec Corporation, MAQUET GmbH & Co, Teleflex Incorporated, Berlin Heart GmbH, Abiomed, Inc., HeartWare International, SynCardia Systems, Inc. are the leading market players with dominance over 60% of the market.
Thoratec Corporation and Berlin Heart are the prominent players in the VAD segment whereas Teleflex and MAQUET are dominant players in the Intra-Aortic Balloon Pumps (IABP) segment. SynCardia is the foremost company to provide the only Food and Drug Administration (FDA) approved Total Artificial Heart (TAH).
Some other potential players in the market include Jarvik Heart, Inc. and Terumo Corporation. Braile Biomedica Ltd., CardiacAssist, Inc., CardioBridge GmbH, Carmat SAS, Cleveland Heart, Inc., CorAssist Cardiovascular Ltd., Evaheart Medical USA, Inc., Leviticus Cardio Ltd., MyoCardioCare, Inc.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!